Super-vaccine trial for coronaviruses set for 2025
Health Policy Watch — May 14, 2024, 05:00 PM UTC
Summary: Researchers have developed an all-in-one coronavirus vaccine to combat various strains, including unknown ones. Published in Nature Nanotechnology, the vaccine, tested successfully on mice, is set for human trials in early 2025. The vaccine's key component is a chain of receptor-binding-domains from different coronaviruses. This proactive vaccinology approach aims to swiftly respond to potential pandemics. The vaccine offers broad immunity, even against unanticipated coronaviruses.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.